Aoyuan Cui

1.5k total citations
18 papers, 960 citations indexed

About

Aoyuan Cui is a scholar working on Molecular Biology, Epidemiology and Physiology. According to data from OpenAlex, Aoyuan Cui has authored 18 papers receiving a total of 960 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Epidemiology and 5 papers in Physiology. Recurrent topics in Aoyuan Cui's work include Liver Disease Diagnosis and Treatment (10 papers), Fibroblast Growth Factor Research (3 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). Aoyuan Cui is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Fibroblast Growth Factor Research (3 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). Aoyuan Cui collaborates with scholars based in China, United States and Hong Kong. Aoyuan Cui's co-authors include Yu Li, Yamei Han, Jing Gao, Zhengshuai Liu, Fengguang Ma, Zhimin Hu, Yaqian Xue, Jian‐Gao Fan, Yuxiao Liu and Qiyong Gong and has published in prestigious journals such as Nature Communications, Hepatology and Diabetes.

In The Last Decade

Aoyuan Cui

17 papers receiving 947 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aoyuan Cui China 11 529 400 219 144 143 18 960
Maximilian Hatting Germany 15 464 0.9× 344 0.9× 191 0.9× 164 1.1× 158 1.1× 22 1.0k
Toshio Hosaka Japan 19 662 1.3× 174 0.4× 286 1.3× 225 1.6× 235 1.6× 53 1.2k
Rosario Hernández Spain 14 629 1.2× 510 1.3× 474 2.2× 174 1.2× 141 1.0× 18 1.3k
Hui‐Chen Ku Taiwan 11 454 0.9× 283 0.7× 311 1.4× 99 0.7× 81 0.6× 20 1.0k
Leela Goodspeed United States 16 318 0.6× 401 1.0× 287 1.3× 167 1.2× 180 1.3× 24 956
Osamu Sekine Japan 18 415 0.8× 216 0.5× 261 1.2× 192 1.3× 144 1.0× 47 1.1k
Kahealani Uehara United States 11 387 0.7× 321 0.8× 320 1.5× 232 1.6× 82 0.6× 14 858
Joo Sun Choi South Korea 16 340 0.6× 190 0.5× 221 1.0× 201 1.4× 164 1.1× 18 937
Yonggang Lu China 14 446 0.8× 220 0.6× 166 0.8× 127 0.9× 174 1.2× 23 909
Mayuko Ichimura‐Shimizu Japan 15 307 0.6× 305 0.8× 166 0.8× 146 1.0× 85 0.6× 65 762

Countries citing papers authored by Aoyuan Cui

Since Specialization
Citations

This map shows the geographic impact of Aoyuan Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aoyuan Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aoyuan Cui more than expected).

Fields of papers citing papers by Aoyuan Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aoyuan Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aoyuan Cui. The network helps show where Aoyuan Cui may publish in the future.

Co-authorship network of co-authors of Aoyuan Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Aoyuan Cui. A scholar is included among the top collaborators of Aoyuan Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aoyuan Cui. Aoyuan Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Liu, Zhengshuai, Yang Jiang, Fengguang Ma, et al.. (2025). Protein phosphatase 6 regulates metabolic dysfunction-associated steatohepatitis via the mTORC1 pathway. Journal of Hepatology. 83(3). 630–642. 1 indexed citations
2.
Zhong, Jing, Yali Zhao, Jinghuan Lv, et al.. (2024). Identification of BAF60b as a Chromatin-Remodeling Checkpoint of Diet-Induced Fatty Liver Disease. Diabetes. 73(10). 1615–1630. 1 indexed citations
3.
Jiang, Yang, Yuxiao Liu, Dong Ding, et al.. (2024). Ethyl Lactate Ameliorates Hepatic Steatosis and Acute‐on‐Chronic Liver Injury in Alcohol‐Associated Liver Disease by Inducing Fibroblast Growth Factor 21. Advanced Science. 12(5). e2409516–e2409516. 4 indexed citations
4.
Hu, Kai, Aoyuan Cui, & Xiao Zhang. (2023). Intergenerational relationship between parental famine exposure and offspring’s obesity risks. Journal of Epidemiology & Community Health. 78(3). 160–167.
5.
6.
Cui, Aoyuan, Dong Ding, & Yu Li. (2021). Regulation of Hepatic Metabolism and Cell Growth by the ATF/CREB Family of Transcription Factors. Diabetes. 70(3). 653–664. 47 indexed citations
7.
Shi, Dawei, Xian Xia, Aoyuan Cui, et al.. (2020). The precursor of PI(3,4,5)P3 alleviates aging by activating daf-18(Pten) and independent of daf-16. Nature Communications. 11(1). 4496–4496. 18 indexed citations
8.
Cui, Aoyuan, Jian Li, Shaohui Ji, et al.. (2020). The Effects of B1344, a Novel Fibroblast Growth Factor 21 Analog, on Nonalcoholic Steatohepatitis in Nonhuman Primates. Diabetes. 69(8). 1611–1623. 42 indexed citations
9.
Han, Yamei, Zhimin Hu, Aoyuan Cui, et al.. (2019). Post-translational regulation of lipogenesis via AMPK-dependent phosphorylation of insulin-induced gene. Nature Communications. 10(1). 623–623. 115 indexed citations
10.
Zhao, Zehua, Feng‐Zhi Xin, Yaqian Xue, et al.. (2019). Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats. Experimental & Molecular Medicine. 51(9). 1–14. 251 indexed citations
11.
Hu, Zhimin, Yuxiao Liu, Zhengshuai Liu, et al.. (2019). 265-OR: Myeloid CREBZF Couples Inflammatory Signals to Systemic Insulin Resistance by Regulating Immune Response of the Adipose Tissue. Diabetes. 68(Supplement_1). 1 indexed citations
12.
Cui, Aoyuan, Zhengshuai Liu, Fengguang Ma, et al.. (2019). 311-OR: CREBZF as a Novel Target of Glucose Sensing Signaling in the Control of Adaptive Thermogenesis in the Adipose Tissue. Diabetes. 68(Supplement_1). 1 indexed citations
13.
Zhang, Feifei, Zhimin Hu, Gaopeng Li, et al.. (2018). Hepatic CREBZF couples insulin to lipogenesis by inhibiting insig activity and contributes to hepatic steatosis in diet‐induced insulin‐resistant mice. Hepatology. 68(4). 1361–1375. 35 indexed citations
14.
Sun, Yixuan, Mingfeng Xia, Hongmei Yan, et al.. (2017). Berberine attenuates hepatic steatosis and enhances energy expenditure in mice by inducing autophagy and fibroblast growth factor 21. British Journal of Pharmacology. 175(2). 374–387. 123 indexed citations
15.
Cui, Aoyuan, Zhimin Hu, Yamei Han, Yi‐Ching Yang, & Yu Li. (2017). Optimized Analysis of <em>In Vivo</em> and <em>In Vitro</em> Hepatic Steatosis. Journal of Visualized Experiments. 21 indexed citations
16.
Cui, Aoyuan, Zhimin Hu, Yamei Han, Yi‐Ching Yang, & Yu Li. (2017). Optimized Analysis of <em>In Vivo</em> and <em>In Vitro</em> Hepatic Steatosis. Journal of Visualized Experiments. 1 indexed citations
17.
Gong, Qiyong, Zhimin Hu, Feifei Zhang, et al.. (2016). Fibroblast growth factor 21 improves hepatic insulin sensitivity by inhibiting mammalian target of rapamycin complex 1 in mice. Hepatology. 64(2). 425–438. 140 indexed citations
18.
Chen, Xüqing, Feifei Zhang, Qiyong Gong, et al.. (2016). Hepatic ATF6 Increases Fatty Acid Oxidation to Attenuate Hepatic Steatosis in Mice Through Peroxisome Proliferator–Activated Receptor α. Diabetes. 65(7). 1904–1915. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maximilian Hatting Breakdown of academic impact, for papers by Toshio Hosaka Breakdown of academic impact, for papers by Rosario Hernández Breakdown of academic impact, for papers by Hui‐Chen Ku Breakdown of academic impact, for papers by Leela Goodspeed Breakdown of academic impact, for papers by Osamu Sekine Breakdown of academic impact, for papers by Kahealani Uehara Breakdown of academic impact, for papers by Joo Sun Choi Breakdown of academic impact, for papers by Yonggang Lu Breakdown of academic impact, for papers by Mayuko Ichimura‐Shimizu
Rankless by CCL
2026